RNLX insider filings
Renalytix plc — 15 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2024-11-05. Screen RNLX transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for RNLX between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — Renalytix plc
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2024-11-05 | 4 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI — 10% owner MOUNT SINAI HEALTH SYSTEM, INC. — 10% owner MOUNT SINAI HOSPITAL — 10% owner MOUNT SINAI HOSPITALS GROUP, INC. — 10% owner | Other (J): 13,366,750 @ $0.12 | EDGAR |
| 2024-06-13 | 4 | Jung Joel R — Interim Chief Financial Office | Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2024-04-26 | 4 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI — 10% owner MOUNT SINAI HOSPITAL — 10% owner MOUNT SINAI HEALTH SYSTEM, INC. — 10% owner MOUNT SINAI HOSPITALS GROUP, INC. — 10% owner | Other (J): 9,360,374 @ $0.25 | EDGAR |
| 2023-11-22 | 4 | Coste Catherine — Director | Grant/award (A): 95,000 (derivative) @ $0 | EDGAR |
| 2023-11-22 | 4 | Parikh Chirag R. — Director | Grant/award (A): 95,000 (derivative) @ $0 | EDGAR |
| 2023-11-22 | 4 | Doran Howard JR — Chief Business Officer | Grant/award (A): 300,000 (derivative) @ $0 | EDGAR |
| 2023-11-22 | 4 | MILLS CHRISTOPHER — Director, 10% owner | Grant/award (A): 95,000 (derivative) @ $0 | EDGAR |
| 2023-11-22 | 4 | LEVANGIE DANIEL J — Director | Grant/award (A): 95,000 (derivative) @ $0 | EDGAR |
| 2023-07-11 | 4 | MCLAIN THOMAS H — President | Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
| 2023-07-07 | 4 | Donovan Michael J. — Chief Medical Officer | Grant/award (A): 85,731 (derivative) @ $0 | EDGAR |
| 2023-07-07 | 4 | Coste Catherine — Director | Grant/award (A): 190,000 (derivative) @ $0 | EDGAR |
| 2023-07-07 | 4 | McCullough James Renwick — Chief Executive Officer, Director | Grant/award (A): 875,017 (derivative) @ $0 | EDGAR |
| 2023-07-07 | 4 | Fleming Fergus — Chief Technical Officer, Director | Grant/award (A): 352,902 (derivative) @ $0 | EDGAR |
| 2023-07-07 | 4 | Sterling O. James — Chief Financial Officer | Grant/award (A): 575,160 (derivative) @ $0 | EDGAR |
| 2023-07-07 | 4 | MCLAIN THOMAS H — President | Grant/award (A): 394,486 (derivative) @ $0 | EDGAR |
Recent 8-K events — Renalytix plc
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2025-01-16 | 8-K | 7.01 — Regulation FD Disclosure | EDGAR |
| 2024-12-20 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-11-19 | 8-K/A | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-11-06 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-10-01 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.01 — Completion of Acquisition or Disposition of Assets 2.02 — Results of Operations and Financial Condition 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.02 — Unregistered Sales of Equity Securities 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-08-27 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-07-15 | 8-K | 3.02 — Unregistered Sales of Equity Securities 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-06-25 | 8-K/A | 4.01 — Changes in Registrant's Certifying Accountant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-06-24 | 8-K | 4.01 — Changes in Registrant's Certifying Accountant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-06-24 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=RNLX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs